Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 57,180 shares at $13.79 ($758K) on 2026-04-09, disclosed to the SEC on 2026-04-13.
Scheduled sale ($758k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.79 | 16,960 | $234K | 30.9% |
| 2 | $14.44 | 2,100 | $30K | 4.0% |
| 3 | $12.75 | 18,660 | $238K | 31.4% |
| 4 | $13.48 | 400 | $5K | 0.7% |
| 5 | $12.95 | 15,722 | $204K | 26.9% |
| 6 | $14.08 | 3,338 |
| $47K |
| 6.2% |
| Total | $13.26 avg | 57,180 | $758K | 100% |
| Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |
| ADPT | SELL | 2026-04-21 | $1.0M | — | Filing → |